H.Res. 484 · 117th Congress · House

Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID-19 vaccines or treatments.

Active· Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
Introduced
Jun 17, 21
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

This resolution expresses the sense of the House of Representatives that the United States should not waive intellectual property protections for COVID-19 vaccines, treatments, or other related innovations.

Action Timeline

4
  1. NOV 01, 2022•Committee

    Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.

  2. JUN 17, 2021•IntroReferral

    Introduced in House

  3. JUN 17, 2021•IntroReferral

    Introduced in House

  4. JUN 17, 2021•IntroReferral

    Referred to the House Committee on the Judiciary.

Committees

2

Courts, Intellectual Property, Artificial Intelligence, and the Internet Subcommittee

hsju03

Referred: Nov 1, 2022

Active

Judiciary Committee

hsju00

Referred: Jun 17, 2021

Active